好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Assessing Hemorrhagic Risk after Revascularization in Acute Ischemic Stroke: The Role of the HAS-BLED Score
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:00 PM-6:00 PM)
4-022

Evaluating the predictive value of the HAS-BLED score for hemorrhagic transformation in patients with acute ischemic stroke (AIS) undergoing revascularization therapies.


Hemorrhagic transformation, a common complication after reperfusion in AIS, limits therapeutic benefit and worsens outcomes. Although several predictive models exist, none are routinely used in practice. The HAS-BLED score, which estimates bleeding risk in atrial fibrillation, incorporates variables relevant to AIS and may help predict hemorrhagic risk after revascularization.

Retrospective observational study of AIS patients treated with reperfusion therapies at a Dominican stroke unit (January 2024-June 2025). Data from the Res-Q registry and electronic medical records were used to compute the HAS-BLED score. A multivariable binary logistic regression model was built using SPSS version 31, including age ≥80 years old, NIHSS ≥10, wake-up stroke, and revascularization procedure as covariates.


A total 294 AIS patients were analyzed; 20.1% (n=59) underwent reperfusion therapy (49.2% [n=29] thrombolysis, 33.9% [n=20] thrombectomy, and 16.9% [n=10] both). Half were male, 30.5% had hypertension. Median age was 75 years (IQR 16), and median NIHSS was 10 (IQR 10). Hemorrhagic transformation occurred in 40.7% (n=24). Median HAS-BLED was 2 (IQR 2). In multivariable analysis, HAS-BLED ≥3 was associated with higher odds of hemorrhagic transformation (aOR 2.19; 95% CI 0.59–8.10; p= 0.24), though not significant. Age ≥80 was independently protective (aOR 0.22; 95% CI 0.06–0.84; p= 0.027), and NIHSS >10 showed a borderline association with increased risk (aOR 3.52; 95% CI 0.91–13.62; p = 0.068). Revascularization type and wake-up stroke were not significant predictors.

The HAS-BLED score did not reliably predict hemorrhagic transformation after reperfusion in AIS. Although higher scores showed a nonsignificant trend toward increased risk, the model lacked discriminatory value. Age and baseline stroke severity were stronger predictors. These findings suggest that HAS-BLED is not an adequate tool for estimating post-revascularization hemorrhagic risk in this population.
Authors/Disclosures
Jose De Los Santos, MD
PRESENTER
Dr. De Los Santos has nothing to disclose.
Deyrha Jennifer Mills, MD (CEDIMAT) Dr. Mills has nothing to disclose.
Stephanie Castro Turbi, MD (CEDIMAT) Dr. Castro Turbi has nothing to disclose.
Edwina L. Luna Rodríguez, MD (CEDIMAT) Dr. Luna Rodríguez has nothing to disclose.
Diego J. Gil Troncoso, MD Mr. Gil Troncoso has nothing to disclose.